Fujifilm Irvine Scientific Launches BalanCD Gal Supplement for Biotherapeutic Development
September 10, 2019
September 10, 2019
VALHALLA, New York, Sept. 10 -- Fujifilm USA issued the following news:
FUJIFILM Irvine Scientific, Inc., a world leader in the optimization, development and manufacture of cell culture media and industrial cell culture solutions, today introduced BalanCD Gal Supplement. The new formula has been developed to increase galactosylation in biotherapeutic development, to help achieve desired glycan profiles for improved product quality and antibody efficacy.
Glycosylation is . . .
FUJIFILM Irvine Scientific, Inc., a world leader in the optimization, development and manufacture of cell culture media and industrial cell culture solutions, today introduced BalanCD Gal Supplement. The new formula has been developed to increase galactosylation in biotherapeutic development, to help achieve desired glycan profiles for improved product quality and antibody efficacy.
Glycosylation is . . .